A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors

Clinical trial NCT05712356 · TERMINATED

Trial details

NCT number: NCT05712356
Sponsor: Lisata Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cholangiocarcinoma Gallbladder Cancer Gallbladder Carcinoma Intrahepatic Cholangiocarcinoma Extrahepatic Cholangiocarcinoma Bile Duct Cancer Gall Bladder Cancer Gall Bladder Carcinoma

Start date: 2023-05-13
Primary completion: 2026-04-05
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.